Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is 9.08% vs 12.83% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 52.44% vs 17.62% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 30.49% vs 47.75% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -50.00% vs 144.44% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Bide Pharmatech Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is -6.21% vs -1.96% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 9.08% vs 12.83% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 46.25% vs -30.89% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 52.44% vs 17.62% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 27.13% vs -25.30% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 30.49% vs 47.75% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is -8.33% vs 9.09% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -50.00% vs 144.44% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






